questionText: To ask the Secretary of State for Health and Social Care, which NHS bodies have a role in the consideration of Abiraterone for inclusion in the drug repurposing programme for the treatment of locally advanced high-risk non-metastatic prostate cancer; and 
answerText: The national, multi-agency Medicines Repurposing Programme is hosted and funded by NHS England and is overseen by a steering group, including decision-making members from the Department, the Medicines and Healthcare products Regulatory Agency, the Nationa...
heading: Abiraterone